Search results
Tandem Diabetes Care (NASDAQ:TNDM) Given New $55.00 Price Target at Stifel Nicolaus
ETF DAILY NEWS· 4 days agoTandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective boosted by Stifel Nicolaus from $45.00 to $55.00 in a research note published on Wednesday morning ...
"I showed you all": Lizzo gratified "South Park" presents her body positivity as weight loss answer
Salon via Yahoo News· 2 hours agoA few like Stan's mom Sharon, however, are out of luck. Her insurance won't cover the drugs since...
Use of Wegovy and other weight-loss drugs soars among kids and young adults
La Crosse Tribune· 8 hours agoUse of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has...
Experts demand obesity action to cure sick note Britain after diabetes surge
Daily Express· 5 days agoExperts are demanding a “tough love” crackdown on obesity to cure sick note Britain after a report...
Column: Expand preventative services to reduce diabetes cases
The Virginian-Pilot· 5 days agoIt is no secret that Type 2 diabetes (T2D) is one of the most common chronic diseases in the United...
Use of Wegovy and other weight-loss drugs soars among kids and young adults
The Chippewa Herald· 8 hours agoUse of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has...
Prescriptions for weight loss, diabetes drugs for young people leaped 600% since 2020, study says
CNN via Yahoo News· 3 days agoThe number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic for weight loss and diabetes soared 594.4% in just three years, according to new research.
First pill for postpartum depression is now out, turns to be effective
Interesting Engineering· 59 minutes agoFrom the look of it might not seem to be serious, however, postpartum depression is quite real and...
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up After Analyst Upgrade
ETF DAILY NEWS· 3 days agoTandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) shares gapped up before the market opened on Wednesday after Lake Street Capital raised their price target on the ...
Eli Lilly's diabetes drug tirzepatide gets approval in China
AOL· 6 days agoSHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying competition with its Danish ...